StocksFundsScreenerSectorsWatchlists
LFVN

LFVN - Lifevantage Corp Stock Price, Fair Value and News

6.70USD+0.10 (+1.52%)Market Closed

Market Summary

LFVN
USD6.70+0.10
Market Closed
1.52%

LFVN Stock Price

View Fullscreen

LFVN RSI Chart

LFVN Valuation

Market Cap

84.9M

Price/Earnings (Trailing)

28.68

Price/Sales (Trailing)

0.4

EV/EBITDA

8.85

Price/Free Cashflow

8.05

LFVN Price/Sales (Trailing)

LFVN Profitability

EBT Margin

1.87%

Return on Equity

10.84%

Return on Assets

4.72%

Free Cashflow Yield

12.42%

LFVN Fundamentals

LFVN Revenue

Revenue (TTM)

210.9M

Rev. Growth (Yr)

-3.8%

Rev. Growth (Qtr)

0.51%

LFVN Earnings

Earnings (TTM)

3.0M

Earnings Growth (Yr)

38%

Earnings Growth (Qtr)

-204.29%

Breaking Down LFVN Revenue

Last 7 days

6.7%

Last 30 days

-5.2%

Last 90 days

14.5%

Trailing 12 Months

105.2%

How does LFVN drawdown profile look like?

LFVN Financial Health

Current Ratio

1.68

LFVN Investor Care

Shares Dilution (1Y)

1.19%

Diluted EPS (TTM)

0.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023210.1M213.4M213.0M210.9M
2022210.2M206.4M204.9M206.4M
2021224.8M220.2M218.6M211.8M
2020229.7M232.9M231.5M229.3M
2019223.8M226.0M226.6M229.7M
2018199.8M203.2M209.7M218.4M
2017201.9M199.5M193.7M194.3M
2016198.8M206.5M216.1M213.0M
2015201.1M190.3M184.1M187.8M
2014209.4M214.0M214.3M211.0M
2013201.3M208.2M206.6M204.7M
201296.6M126.2M159.0M187.1M
2011038.9M52.6M70.4M
20100000
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Lifevantage Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
aure carl
sold (taxes)
-12,709
6.39
-1,989
chief financial officer
Apr 01, 2024
boyster julie
acquired
-
-
3,668
chief marketing officer
Apr 01, 2024
neufeld alissa
acquired
-
-
2,668
general counsel
Apr 01, 2024
cunningham kristen
acquired
-
-
3,001
chief sales officer
Apr 01, 2024
fife steven r
acquired
-
-
20,234
president and ceo
Apr 01, 2024
cunningham kristen
sold (taxes)
-11,687
6.39
-1,829
chief sales officer
Apr 01, 2024
boyster julie
sold (taxes)
-14,083
6.39
-2,204
chief marketing officer
Apr 01, 2024
fife steven r
sold (taxes)
-96,533
6.39
-15,107
president and ceo
Apr 01, 2024
neufeld alissa
sold (taxes)
-16,895
6.39
-2,644
general counsel
Apr 01, 2024
aure carl
acquired
-
-
2,401
chief financial officer

1–10 of 50

Which funds bought or sold LFVN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 16, 2024
Asset Dedication, LLC
sold off
-100
-
-
-%
Apr 15, 2024
Sound Income Strategies, LLC
added
0.46
53.00
3,953
-%
Apr 15, 2024
St. Johns Investment Management Company, LLC
unchanged
-
104
12,554
0.01%
Apr 12, 2024
New England Professional Planning Group Inc.
added
0.51
896
67,578
0.04%
Mar 11, 2024
VANGUARD GROUP INC
unchanged
-
-207,995
2,773,270
-%
Feb 28, 2024
EP Wealth Advisors, LLC
unchanged
-
-8,752
116,694
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
unchanged
-
-9,000
125,000
-%
Feb 16, 2024
HARBOUR INVESTMENTS, INC.
unchanged
-
-506
6,750
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
252
252
-%
Feb 15, 2024
BARCLAYS PLC
unchanged
-
-14,000
182,000
-%

1–10 of 45

Are Funds Buying or Selling LFVN?

Are funds buying LFVN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own LFVN
No. of Funds

Unveiling Lifevantage Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 15, 2024
sudbury capital management, llc
5.8%
749,325
SC 13D/A
Feb 15, 2024
radoff bradley louis
6.7%
50,000
SC 13D/A
Feb 13, 2024
renaissance technologies llc
6.51%
838,118
SC 13G/A
Nov 14, 2023
sudbury capital management, llc
5.9%
749,325
SC 13D/A
Nov 14, 2023
radoff bradley louis
6.8%
50,000
SC 13D/A
Aug 11, 2023
sudbury capital fund, lp
5.7%
732,821
SC 13D/A
Aug 11, 2023
radoff bradley louis
6.6%
30,000
SC 13D/A
May 15, 2023
radoff bradley louis
5.7%
25,728
SC 13D
Feb 13, 2023
renaissance technologies llc
6.76%
858,718
SC 13G/A
Feb 09, 2023
vanguard group inc
3.69%
463,326
SC 13G/A

Recent SEC filings of Lifevantage Corp

View All Filings
Date Filed Form Type Document
Apr 16, 2024
8-K
Current Report
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Mar 18, 2024
4
Insider Trading
Feb 28, 2024
4
Insider Trading
Feb 21, 2024
4
Insider Trading
Feb 15, 2024
SC 13D/A
13D - Major Acquisition

Peers (Alternatives to Lifevantage Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
30.8B
93.9B
0.03% -26.80%
8.85
0.33
-7.50% -19.75%
15.3B
61.3B
8.98% 7.74%
7.7
0.25
-8.91% 30.43%
14.5B
12.1B
7.19% -18.68%
15.19
1.19
-0.78% 18.26%
12.9B
9.3B
- -21.41%
16.86
1.39
1.02% -5.78%
11.8B
79.2B
-1.92% -1.59%
8.67
0.15
3.12% -18.15%
MID-CAP
7.1B
1.7B
-10.60% 54.95%
43.07
4.1
21.49% 39.64%
5.1B
766.9M
-3.07% 61.07%
-151.07
6.62
28.82% 43.50%
4.9B
5.1B
2.55% -14.12%
39.8
0.96
5.93% -45.96%
2.9B
2.4B
-0.08% 5.67%
10.66
1.24
-22.17% -63.60%
2.6B
3.3B
-6.24% 25.49%
19.53
0.79
0.37% -0.15%
SMALL-CAP
1.9B
14.8B
6.71% 31.24%
18.95
0.13
-14.86% -22.80%
834.2M
2.1B
0.47% -28.21%
-12.6
0.4
-4.65% -482.22%
415.9M
343.4M
-22.62% -56.61%
-1.23
1.21
-18.04% 7.65%
203.1M
106.3M
-3.04% 8.15%
4.24
1.91
34.67% 5930.90%
6.8M
2.5M
-21.88% 207.02%
-0.24
2.73
-21.18% -24.37%

Lifevantage Corp News

Latest updates
Yahoo Movies UK • 13 Apr 2024 • 06:00 am
Simply Wall St • 27 Mar 2024 • 07:00 am
Defense World • 26 Mar 2024 • 07:00 am
Yahoo Finance • 15 Mar 2024 • 07:00 am

Lifevantage Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue0.5%51,62451,36454,22153,74153,66251,77450,94350,00452,18953,22454,77751,57059,00754,82759,36856,07761,24256,22856,17056,01258,167
Gross Profit-1.5%40,55841,18443,15243,12341,90441,83241,61140,34742,51243,79344,99542,75248,81845,42949,91946,98251,01247,03846,46046,74248,373
Operating Expenses3.4%41,81940,43540,55041,52443,13640,54240,11538,52242,87039,18138,41440,66443,36941,93243,71043,94947,36644,46040,79244,50147,792
  S&GA Expenses11.7%20,06517,96217,04817,70819,58016,72915,61215,31617,42115,07612,81115,51016,21816,29914,81617,28118,13117,68615,33817,29619,616
EBITDA Margin1.4%0.04*0.04*0.03*0.02*0.02*0.02*0.04*0.07*0.07*0.10*0.09*0.09*---------
Interest Expenses-35.7%108168-28959.0032.00-17.00-5.00-1.003.00-2.009.006.001.0030.0041.0048.0041.0072.00100
Income Taxes-328.0%-456200612643-17.00200422610-5771,1161,5711071,7618992,2591,005-8467001,573376-420
Earnings Before Taxes-234.1%-1,1128292,5571,665-1,075852-9941,751-4984,4326,4781,8315,5733,3506,0882,6663,4572,4505,4982,158409
EBT Margin0.0%0.02*0.02*0.02*0.00*0.00*0.01*0.02*0.06*0.06*0.08*0.08*0.07*---------
Net Income-204.3%-6566291,9661,022-1,058610-1,4161,14179.003,3164,9071,7243,8122,4513,8241,6614,3031,7613,9071,782829
Net Income Margin16.8%0.01*0.01*0.01*0.00*0.00*0.00*0.02*0.04*0.05*0.06*0.06*0.05*---------
Free Cashflow-66.6%1,2143,6323,2502,453130-2,0722,5143063,52287.007,8941,330---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-5.9%63.0067.0066.0067.0068.0068.0071.0072.0072.0076.0079.0075.0074.0070.0059.0052.0055.0056.0055.0054.0054.00
  Current Assets-7.7%39.0042.0044.0044.0044.0043.0047.0045.0043.0045.0048.0044.0042.0041.0044.0038.0038.0042.0043.0043.0044.00
    Cash Equivalents-5.8%17.0018.0022.0020.0017.0018.0020.0018.0020.0020.0023.0019.0020.0018.0022.0013.0014.0013.0019.0016.0019.00
  Inventory-4.7%15.0016.0016.0018.0020.0019.0016.0016.0015.0016.0016.0015.0015.0015.0014.0015.0014.0015.0014.0014.0013.00
  Net PPE-3.7%9.009.009.009.009.009.0010.0010.0010.0011.0011.0011.0011.007.007.007.008.007.007.007.006.00
Liabilities-5.2%35.0037.0031.0034.0036.0036.0039.0038.0037.0038.0042.0039.0039.0036.0026.0024.0026.0026.0028.0029.0033.00
  Current Liabilities-6.8%23.0025.0020.0021.0023.0023.0026.0024.0022.0022.0025.0022.0022.0022.0025.0023.0025.0025.0026.0027.0029.00
  Long Term Debt---------------------2.00
    LT Debt, Current-----------------0.001.001.002.002.00
    LT Debt, Non Current---------------------2.00
Shareholder's Equity-6.8%27.0029.0035.0033.0032.0032.0032.0034.0035.0037.0037.0036.0036.0034.0033.0029.0029.0030.0027.0025.0021.00
  Retained Earnings-2.9%-106-104-98.30-99.00-99.64-98.20-98.44-96.18-95.60-92.52-92.35-93.32-93.04-92.86-93.31-97.13-96.79-99.08-99.96-100-102
  Additional Paid-In Capital0.4%135135134133133132131131131130129129128127126126126129127126124
Shares Outstanding1.4%13.0013.0013.0013.0013.0012.0012.0013.0013.0013.0014.0014.00---------
Float-----44.00---81.00---132---223---188
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-63.1%1,7574,7653,7633,443967-1,3452,7806714,0434658,3743,0595,893-1,0539,3493,2129,225-3,4606,9843,8634,576
  Share Based Compensation-23.3%750978946817823602406-38.00755645-79.006689834648381,1631,5461,3721,3891,0831,720
Cashflow From Investing52.1%-543-1,133-505-990-837-727-266-365-521-378-473-1,729-572-960-574-474-881-752-817-1,417-786
Cashflow From Financing61.8%-2,544-6,668-1,323-306-400-328-882-1,562-3,185-3,323-3,676-1,853-3,675-2,249-148-3,852-6,818-1,604-3,313-5,492-1,988
  Dividend Payments-91.8%4555,534445383381377378--------------
  Buy Backs139.0%1,900795822---4271,7003,1543,4923,9002,0004,0002,000-2,0002,0121,3932,9492061,500

LFVN Income Statement

2023-12-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue, net$ 51,624$ 53,662$ 102,988$ 105,436
Cost of sales11,06611,75821,24621,700
Gross profit40,55841,90481,74283,736
Operating expenses:    
Commissions and incentives21,75423,55644,22747,369
Selling, general and administrative20,06519,58038,02736,310
Total operating expenses41,81943,13682,25483,679
Operating (loss) income(1,261)(1,232)(512)57
Other income (expense):    
Interest income, net1083227632
Other income (expense), net41125(47)(312)
Total other income (expense)149157229(280)
Loss before income taxes(1,112)(1,075)(283)(223)
Income tax benefit (expense)45617256(225)
Net loss$ (656)$ (1,058)$ (27)$ (448)
Net loss per share:    
Basic (in USD per share)$ (0.05)$ (0.08)$ (0.00)$ (0.04)
Diluted (in USD per share)$ (0.05)$ (0.08)$ (0.00)$ (0.04)
Weighted-average shares outstanding:    
Basic (in shares)12,61212,54312,57412,500
Diluted (in shares)12,61212,54312,57412,500
Other comprehensive income, net of tax:    
Foreign currency translation adjustment$ 463$ 640$ 169$ 130
Other comprehensive income, net of tax463640169130
Comprehensive income (loss)$ (193)$ (418)$ 142$ (318)

LFVN Balance Sheet

2023-12-31
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Dec. 31, 2023
Jun. 30, 2023
Current assets  
Cash and cash equivalents$ 17,331$ 21,605
Accounts receivable2,3351,612
Income tax receivable234241
Inventory, net14,97216,073
Prepaid expenses and other3,7894,753
Total current assets38,66144,284
Long-term assets  
Property and equipment, net8,9709,086
Right-of-use assets9,5268,738
Intangible assets, net389455
Deferred income tax asset4,6182,991
Other long-term assets518569
TOTAL ASSETS62,68266,123
Current liabilities  
Accounts payable6,2373,505
Commissions payable6,7986,651
Income tax payable8250
Lease liabilities1,6461,521
Other accrued expenses7,5117,932
Total current liabilities23,01719,609
Long-term lease liabilities12,13311,566
Other long-term liabilities225299
Total liabilities35,37531,474
Commitments and contingencies - Note 7
Stockholders’ equity  
Preferred stock — par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding00
Common stock — par value $0.0001 per share, 40,000 shares authorized and 12,880 and 12,622 issued and outstanding as of December 31, 2023 and June 30, 2023, respectively11
Additional paid-in capital135,490134,314
Accumulated deficit(106,992)(98,305)
Accumulated other comprehensive loss(1,192)(1,361)
Total stockholders’ equity27,30734,649
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$ 62,682$ 66,123
LFVN
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.
 CEO
 WEBSITElifevantage.com
 INDUSTRYPackaged Foods
 EMPLOYEES248

Lifevantage Corp Frequently Asked Questions


What is the ticker symbol for Lifevantage Corp? What does LFVN stand for in stocks?

LFVN is the stock ticker symbol of Lifevantage Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lifevantage Corp (LFVN)?

As of Wed Apr 17 2024, market cap of Lifevantage Corp is 84.93 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LFVN stock?

You can check LFVN's fair value in chart for subscribers.

What is the fair value of LFVN stock?

You can check LFVN's fair value in chart for subscribers. The fair value of Lifevantage Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Lifevantage Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LFVN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Lifevantage Corp a good stock to buy?

The fair value guage provides a quick view whether LFVN is over valued or under valued. Whether Lifevantage Corp is cheap or expensive depends on the assumptions which impact Lifevantage Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LFVN.

What is Lifevantage Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, LFVN's PE ratio (Price to Earnings) is 28.68 and Price to Sales (PS) ratio is 0.4. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LFVN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Lifevantage Corp's stock?

In the past 10 years, Lifevantage Corp has provided -0.031 (multiply by 100 for percentage) rate of return.